2m 2m 2m 2m 2m 2m 2m
Unitedhealth Gro (UNH)
NYSE
$377.44-$0.48 (-0.13%)
Price as of Jun 03, 2026 6:24 PM EDT- $345.4BMarket Cap
- 29.00%1-Year Change
- Healthcare PlansIndustry
Unitedhealth Gro (UNH)
$377.44-$0.48 (-0.13%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 447.6B +11.81% | 400.3B +7.71% | 371.6B +14.64% | 324.2B +12.71% | |
Cost of Revenue | 50.7B +8.48% | 46.7B +20.44% | 38.8B +15.03% | 33.7B +8.60% | |
Gross Profit | 396.9B +12.25% | 353.6B +6.23% | 332.9B +14.60% | 290.5B +13.21% | |
Sales and Marketing Expense | 59.6B +12.41% | 53.0B -2.96% | 54.6B +14.33% | 47.8B +12.22% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 4.4B +6.39% | 4.1B +3.20% | 4.0B +16.82% | 3.4B +9.57% | |
Total Operating Expenses | 428.6B +16.47% | 368.0B +8.47% | 339.3B +14.72% | 295.7B +12.18% | |
Operating Profit | 19.0B -41.26% | 32.3B -0.22% | 32.4B +13.80% | 28.4B +18.63% | |
Interest Income | 3.9B -24.64% | 5.2B +27.22% | 4.1B +101.43% | 2.0B -12.65% | |
Interest Expense | -4.0B +2.46% | -3.9B +20.33% | -3.2B +55.16% | -2.1B +26.02% | |
Interest Income and Expense and Net | -82.0M -106.33% | 1.3B +53.74% | 843.0M +1,459.68% | -62.0M -109.34% | |
Total Nonoperating Income and Expense | 4.0B +2.46% | 3.9B +20.33% | 3.2B +55.16% | 2.1B +26.02% | |
Income before Taxes | 14.7B -26.77% | 20.1B -31.06% | 29.1B +10.51% | 26.3B +18.08% | |
Income Taxes | 1.9B -60.86% | 4.8B -19.09% | 6.0B +4.63% | 5.7B +24.60% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 12.1B -16.31% | 14.4B -35.64% | 22.4B +11.24% | 20.1B +16.40% | |
Net Income from Continuing Operations Applicable to Common | 14.7B -26.77% | 20.1B -31.06% | 29.1B +10.51% | 26.3B +18.08% | |
Basic EPS and Net Income | 13.28 -15.09% | 15.64 -35.16% | 24.12 +12.34% | 21.47 +17.13% | |
Diluted EPS and Net Income | 13.23 -14.70% | 15.51 -35.00% | 23.86 +12.65% | 21.18 +17.15% | |
Basic Weighted Average Shares | 908.0M -1.41% | 921.0M -0.75% | 928.0M -0.96% | 937.0M -0.64% | |
Diluted Weighted Average Shares | 911.0M -1.94% | 929.0M -0.96% | 938.0M -1.26% | 950.0M -0.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 24.4B -3.74% | 25.3B -0.45% | 25.4B +8.83% | 23.4B +9.31% | |
Short-Term Investments | 3.8B -1.18% | 3.8B -9.52% | 4.2B -7.59% | 4.5B +79.54% | |
Cash and Cash Equivalents and Short-Term Investments | 28.1B -3.41% | 29.1B -1.74% | 29.6B +6.15% | 27.9B +16.75% | |
Total Current Assets | 90.6B +5.60% | 85.8B +9.36% | 78.4B +13.56% | 69.1B +11.84% | |
Accumulated Depreciation | 7.5B +8.25% | 7.0B -0.97% | 7.0B +1.57% | 6.9B +15.65% | |
Property and Plant and Equipment and Net | 10.8B +1.98% | 10.6B -7.83% | 11.4B +13.05% | 10.1B +12.92% | |
Total Long-Term Assets | 23.0B +17.47% | 19.6B +13.25% | 17.3B +15.11% | 15.0B +19.97% | |
Total Assets | 309.6B +3.79% | 298.3B +8.97% | 273.7B +11.40% | 245.7B +15.79% | |
Income Taxes Payable | 2.4B -33.12% | 3.6B +19.83% | 3.0B +9.10% | 2.8B -15.19% | |
Total Short-Term Debt | 6.1B +33.53% | 4.5B +6.34% | 4.3B +37.43% | 3.1B -14.09% | |
Total Current Liabilities | 114.9B +10.72% | 103.8B +4.76% | 99.1B +11.00% | 89.2B +13.98% | |
Total Long-Term Debt | 72.3B -0.05% | 72.4B +24.19% | 58.3B +6.88% | 54.5B +28.62% | |
Total Long-Term Liabilities | 18.2B +14.47% | 15.9B +10.21% | 14.5B +12.65% | 12.8B +8.93% | |
Total Liabilities | 207.9B +6.23% | 195.7B +11.95% | 174.8B +9.69% | 159.4B +17.41% | |
Retained Earnings | 95.6B -0.45% | 96.0B +0.27% | 95.8B +11.16% | 86.2B +11.70% | |
Total Stockholders Equity | 100.1B +1.85% | 98.3B +4.07% | 94.4B +15.93% | 81.5B +8.53% | |
Total Shares Outstanding | 906.0M -0.98% | 915.0M -0.97% | 924.0M -1.07% | 934.0M -0.74% | |
Cash Flow | |||||
Cash from Operating Activities | 19.7B -18.62% | 24.2B -16.73% | 29.1B +10.92% | 26.2B +17.29% | |
Capital Expenditures | 3.6B +3.52% | 3.5B +3.34% | 3.4B +20.84% | 2.8B +14.18% | |
Cash from Investing Activities | -8.7B -57.69% | -20.5B +31.80% | -15.6B -45.31% | -28.5B +174.55% | |
Dividends Paid | 7.9B +5.08% | 7.5B +11.42% | 6.8B +12.85% | 6.0B +13.47% | |
Cash from Financing Activities | -11.6B +231.55% | -3.5B -69.54% | -11.5B -372.81% | 4.2B +156.69% | |
Financials Ratio | |||||
Gross Margin | 88.68% +0.39% | 88.33% -1.38% | 89.57% -0.04% | 89.60% +0.44% | |
Operating Margin | 4.24% -47.47% | 8.07% -7.36% | 8.71% -0.74% | 8.77% +5.25% | |
Return on Assets | 3.97% -21.24% | 5.04% -41.55% | 8.62% -1.94% | 8.79% +4.09% | |
Return on Equity | 12.16% -18.70% | 14.95% -41.25% | 25.45% -1.02% | 25.71% +6.64% | |
Revenue Growth | 11.81% +53.21% | 7.71% -47.33% | 14.64% +15.15% | 12.71% +7.34% | |
Current Ratio | 0.79 -4.62% | 0.83 +4.38% | 0.79 +2.31% | 0.77 -1.88% | |
Cash Ratio | 0.21 -13.04% | 0.24 -4.99% | 0.26 -1.95% | 0.26 -4.10% | |
Debt-to-Equity Ratio | 0.78 +0.08% | 0.78 +18.16% | 0.66 -6.39% | 0.71 +15.42% | |
Debt-to-Assets Ratio | 0.25 -1.78% | 0.26 +12.82% | 0.23 -2.56% | 0.23 +8.16% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow